Upper class drug companies targeting at 100 Billion Won of sales.

100 billion won of the sales is the most attractive target for most of ambitious drug companies to put their ultimate goals this year. It also implies a symbolic number for the upper class drug companies to pursue, including Dongshin, Yungjin, Samjin, Bukwang, Lilly Korea and BMS Korea.

Samjin's strategy to achieve their 100 BW sales target was tuned on which their core competence would be m...